BLOOD-BASED BIOMARKERS FOR PREDICTING POST-STROKE PROGNOSIS: A SCOPING REVIEW OF PENTRAXIN-3, NEUROPENTRAXIN-1, AND NEUROPENTRAXIN-2. magna-neurologica 2026, 4 (2), 175-186. https://doi.org/10.20961/magnaneurologica.v4i2.3308.